| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $4.2M | -10.2% |
| SG&A Expense | $5.8M | -17.9% |
| Operating Income | -$10.0M | +14.9% |
| Pre-tax Income | -$10.3M | +11.3% |
| Net Income | -$10.3M | +11.3% |
| EPS (Basic) | -$1.11 | +51.9% |
| EPS (Diluted) | -$1.11 | +51.9% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $29K | -84.5% |
| Current Assets | $307K | -20.3% |
| Total Assets | $1.0M | -44.2% |
| Current Liabilities | $11.0M | +22.6% |
| Total Liabilities | $11.0M | +14.7% |
| Stockholders' Equity | -$10.0M | -28.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.0M | +23.3% |
| Investing Cash Flow | $12K | +0.0% |
| Financing Cash Flow | $6.9M | -13.6% |